DVAX
Dynavax Technologies Corp
Price:  
12.69 
USD
Volume:  
1,621,844.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

DVAX Relative Valuation

-41.4%
Upside

As of 2025-02-13, the Relative Valuation of Dynavax Technologies Corp (DVAX) is 7.43 USD. This relative valuation is based on P/E multiples. With the latest stock price at 12.69 USD, the upside of Dynavax Technologies Corp based on Relative Valuation is -41.4%.

The range of the Relative Valuation is 5.70 - 9.53 USD.

Range Selected
Trailing P/E multiples 44.5x - 61.2x 52.8x
Forward P/E multiples 36.6x - 48.6x 42.6x
Fair Price 5.70 - 9.53 7.43
Upside -55.1% - -24.9% -41.4%
12.69 USD
Stock Price
7.43 USD
Fair Price

DVAX Relative Valuation - Historical P/E Data

Date P/E
2025-02-07 84.41
2025-02-06 84.15
2025-02-05 84.48
2025-02-04 83.45
2025-02-03 83.06
2025-01-31 83.77
2025-01-30 83.51
2025-01-29 83.32
2025-01-28 83.06
2025-01-27 80.62
2025-01-24 81.78
2025-01-23 82.16
2025-01-22 79.73
2025-01-21 81.39
2025-01-17 79.92
2025-01-16 79.53
2025-01-15 80.11
2025-01-14 80.11
2025-01-13 80.11
2025-01-10 81.07
2025-01-08 81.01
2025-01-07 82.36
2025-01-06 81.91
2025-01-03 83.06
2025-01-02 82.81
2024-12-31 81.97
2024-12-30 82.36
2024-12-27 83.45
2024-12-26 83.64
2024-12-24 82.42
2024-12-23 82.36
2024-12-20 81.65
2024-12-19 81.91
2024-12-18 81.97
2024-12-17 82.81
2024-12-16 82.49
2024-12-13 83.19
2024-12-12 83.38
2024-12-11 82.87
2024-12-10 82.49
2024-12-09 82.42
2024-12-06 82.49
2024-12-05 82.36
2024-12-04 82.74
2024-12-03 82.10
2024-12-02 83.70
2024-11-29 82.55
2024-11-27 82.87
2024-11-26 81.27
2024-11-25 80.17